Zhou Ling-Yun, Su Chang, Liu Tie-Juan, Li Xue-Mei
Ocular Motility Disorder Treatment & Rehabilitation Center, Department of Acupuncture, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, China.
Neural Regen Res. 2018 Oct;13(10):1851-1856. doi: 10.4103/1673-5374.238716.
Objective and accurate assessment of the degree of ocular motor nerve palsy is helpful not only in the evaluation of prognosis, but also for the screening of treatment methods. However, there is currently no comprehensive measure of its severity. In this study, we designed the Ocular Motor Nerve Palsy Scale and investigated its validity and reliability. Six experts were invited to grade and evaluate the scale. The study recruited 106 patients with a definite diagnosis of unilateral isolated ocular motor nerve palsy. Three physicians evaluated the patients using the scale. One of the three physicians evaluated the patients again after 24 hours. The content validity index (CVI) and factor analysis were used to analyze the scale's construct validity. The intraclass correlation coefficient and Cronbach's alpha were used to evaluate the inter-rater and test-retest reliability and the internal consistency. The CVI results (I-CVI = 1.0, S-CVI = 0.9, P = 0.016, K = 1) indicated good content validity. Factor analysis extracted two common factors that accounted for 85.2% of the variance. Furthermore, the load value of each component was above 0.8, indicating good construct validity. The Ocular Motor Nerve Palsy Scale was found to be highly reliable, with an inter-rater reliability intraclass correlation coefficient of 0.965 (P < 0.01), a test-retest reliability intraclass correlation coefficient of 0.976 (P < 0.01), and Cronbach's alpha values of 0.63-0.70. In conclusion, the Ocular Motor Nerve Palsy Scale with good validity and reliability can be used to quantify the severity of ocular motor nerve palsy. This study was registered at Chinese Clinical Trial Registry (registration number: ChiCTR-OOC-17010702).
客观准确地评估动眼神经麻痹的程度不仅有助于预后评估,还能用于筛选治疗方法。然而,目前尚无对其严重程度的综合测量方法。在本研究中,我们设计了动眼神经麻痹量表,并对其有效性和可靠性进行了研究。邀请了六位专家对该量表进行评分和评估。本研究招募了106例确诊为单侧孤立性动眼神经麻痹的患者。三位医生使用该量表对患者进行评估。三位医生中的一位在24小时后再次对患者进行评估。采用内容效度指数(CVI)和因子分析来分析量表的结构效度。使用组内相关系数和克朗巴哈系数来评估评分者间信度、重测信度以及内部一致性。CVI结果(I-CVI = 1.0,S-CVI = 0.9,P = 0.016,K = 1)表明具有良好的内容效度。因子分析提取了两个共同因子,它们解释了85.2%的方差。此外,每个成分的载荷值均高于0.8,表明具有良好的结构效度。结果发现动眼神经麻痹量表具有高度可靠性,评分者间信度组内相关系数为0.965(P < 0.01),重测信度组内相关系数为0.976(P < 0.01),克朗巴哈系数值为0.63 - 0.70。总之,具有良好有效性和可靠性的动眼神经麻痹量表可用于量化动眼神经麻痹的严重程度。本研究已在中国临床试验注册中心注册(注册号:ChiCTR-OOC-17010702)。